Cargando…
miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping
Non-small cell lung cancer (NSCLC) encompasses distinct histopathological subtypes, namely adenocarcinoma (AC) and squamous cell lung carcinoma (SCC), which require precise differentiation for effective treatment strategies. In this study, we present a novel molecular diagnostic model that integrate...
Autores principales: | Charkiewicz, Radoslaw, Sulewska, Anetta, Charkiewicz, Alicja, Gyenesei, Attila, Galik, Bence, Ramlau, Rodryg, Piwkowski, Cezary, Stec, Rafal, Biecek, Przemyslaw, Karabowicz, Piotr, Michalska-Falkowska, Anna, Miltyk, Wojciech, Niklinski, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488146/ https://www.ncbi.nlm.nih.gov/pubmed/37686123 http://dx.doi.org/10.3390/ijms241713318 |
Ejemplares similares
-
Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer
por: Charkiewicz, Radoslaw, et al.
Publicado: (2023) -
A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC
por: Sulewska, Anetta, et al.
Publicado: (2022) -
A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
por: Sulewska, Anetta, et al.
Publicado: (2023) -
miRNA Studies in Glaucoma: A Comprehensive Review of Current Knowledge and Future Perspectives
por: Dobrzycka, Margarita, et al.
Publicado: (2023) -
Applied Molecular-Based Quality Control of Biobanked Samples for Multi-Omics Approach
por: Michalska-Falkowska, Anna, et al.
Publicado: (2023)